2026-01-27 - Analysis Report
**Company Overview**
Oracle is a multinational technology company that provides enterprise software and cloud engineering services.

**Return Rate Comparison**
- Cumulative return of review stock (ORCL): 206.66%
- Cumulative return of comparison stock (S&P 500, VOO): 127.58%
- Divergence (max: 344.10, min: -23.60, current: 71.40, relative divergence: 25.80%)

The review stock's cumulative return (206.66%) is significantly higher than the comparison stock's cumulative return (127.58%). The divergence is 78.08%, indicating a substantial divergence from the S&P 500.

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 4.0% | 15.4% | -4.0% | 1.0  | 129.7B |
| 2017-2019  | 16.0% | 15.4% | -9.0% | 1.0  | 152.2B |
| 2018-2020  | 18.0% | 27.2% | -5.0% | 0.9  | 185.9B |
| 2019-2021  | 63.0% | 27.2% | -1.0% | 0.9  | 250.6B |
| 2020-2022  | 43.0% | 35.2% | 39.0% | 0.9  | 234.8B |
| 2021-2023  | 65.0% | 35.2% | 47.0% | 0.9  | 302.9B |
| 2022-2024  | 129.0% | 23.2% | 100.0% | 1.0  | 478.8B |
| 2023-2025  | 152.0% | 45.2% | 76.0% | 1.4  | 560.0B |

Oracle has shown varying performance over the years, with CAGRs ranging from 4.0% to 152.0%. The average Beta is around 0.9, indicating that Oracle's stock movements are relatively volatile compared to the market.

**Recent Stock Price Fluctuations**
- Close: $182.44
- Last-market: $182.44 (2.98% increase from the previous close)
- 5-day SMA: $178.32
- 20-day SMA: $191.08
- 60-day SMA: $208.18

The stock has seen a recent increase in price, with its 5-day and 20-day SMAs showing a slight decrease in value. The 60-day SMA is the highest among the three, indicating a relatively strong upward trend.

**RSI, PPO Indicators and Expected Return**
- RSI: 42.09
- PPO: -0.47
- Market Risk Indicator (MRI): 0.70
- Expected Return (%): 160.90%

The RSI and PPO indicators suggest that the stock is currently undervalued. The MRI indicates a medium-risk investment opportunity. The Expected Return is significantly high, indicating a potential for long-term growth.

**Recent News & Significant Events**
- Oracle Stock (ORCL) Wobbles as Morgan Stanley Slashes Target 30% 
- Guggenheim Reiterates Buy on Oracle (ORCL), Keeps Stock as Software â€˜Best Idea 
- Options Corner: AI Bubble Fears Have Sharply Discounted Oracle Stock

These recent news articles indicate that Oracle's stock has been affected by Morgan Stanley's target reduction and AI bubble fears, but Guggenheim remains bullish on the stock.

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.77 (~Buy)
- Opinions: 38
- Target Price (avg/high/low): 288.26 / 400.00 / 155.00

The analyst consensus is bullish on Oracle's stock, with a mean rating of 1.77 and a target price of $288.26.

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|----- | --- |---------|
| 2025-12-11 | 2.14 | 16.06 B$ |
| 2025-09-10 | 1.04 | 14.93 B$ |
| 2025-03-11 | 1.05 | 14.13 B$ |
| 2024-12-10 | 1.13 | 14.06 B$ |
| 2025-12-11 | 1.13 | 14.06 B$ |

EPS has ranged from 1.04 to 2.14, indicating a significant increase in profitability. Revenue has also increased, ranging from 14.06 to 16.06 billion dollars.

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-11-30 | $16.06B | 66.53% |
| 2025-08-31 | $14.93B | 67.28% |
| 2025-05-31 | $15.90B | 70.19% |
| 2025-02-28 | $14.13B | 70.31% |
| 2024-11-30 | $14.06B | 70.94% |

Profit margin has ranged from 66.53% to 70.94%, indicating a steady increase in profitability.

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-11-30 | $29.95B | 20.48% |
| 2025-08-31 | $24.15B | 12.12% |
| 2025-05-31 | $20.45B | 16.76% |
| 2025-02-28 | $16.73B | 17.55% |
| 2024-11-30 | $13.75B | 22.92% |

Equity has increased significantly, ranging from 13.75 to 29.95 billion dollars. ROE has ranged from 12.12% to 22.92%, indicating a steady increase in profitability.

**Comprehensive Analysis**
Oracle's stock has shown a high cumulative return compared to the S&P 500. The Alpha, Beta analysis indicates a relatively volatile stock with varying performance over the years. The recent stock price fluctuations suggest a slight decrease in value, but the 60-day SMA indicates a strong upward trend. The RSI and PPO indicators suggest that the stock is undervalued, and the MRI indicates a medium-risk investment opportunity. The Expected Return is significantly high, indicating a potential for long-term growth. The recent news articles indicate that Oracle's stock has been affected by Morgan Stanley's target reduction and AI bubble fears, but Guggenheim remains bullish on the stock. The analyst consensus is bullish, with a mean rating of 1.77 and a target price of $288.26. The recent earnings analysis indicates a significant increase in profitability, and the revenue and profitability analysis shows a steady increase in profitability. The capital and profitability analysis indicates a steady increase in equity and ROE.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.